scholarly journals Efficacy of Lycium barbarum L. on plasma lipid concentration in adults

Medicine ◽  
2021 ◽  
Vol 100 (49) ◽  
pp. e28172
Author(s):  
Xueyuan Zeng ◽  
Weimin Zhao ◽  
Yunlong Xu ◽  
Chengwei Zhang ◽  
Junliang Wu ◽  
...  
Keyword(s):  
Plasma Lipid ◽  
Lipid Concentration ◽  
Lycium Barbarum ◽  
Plasma Lipid Concentration

Heparin

1966 ◽  
Vol 4 (5) ◽  
pp. 17-19
Keyword(s):  
Molecular Weight ◽  
Plasma Lipid ◽  
Lipid Concentration ◽  
Plasma Lipid Concentration ◽  
Mammalian Tissues

Heparin is used to prevent clotting and to alter the plasma lipid concentration. Commercial heparin is a mixture of sulphated mucopolysaccharides of molecular weight about 10000 made from mammalian tissues; present preparations contain about 150 anticoagulant units (BP and USP) heparin/mg. The solution is available in four strengths: 1000, 5000, 10000 and 25000 units/ml.

scholarly journals Developmental Changes in the Late Larva of Calliphora Stygia I. Haemolymph

1968 ◽  
Vol 21 (5) ◽  
pp. 1033 ◽  
Author(s):  
Judith F Kinnear ◽  
Marjory D Martin JA Thomson ◽  
GJ Neufeld
Keyword(s):  
Plasma Protein ◽  
Plasma Levels ◽  
Plasma Lipid ◽  
Developmental Changes ◽  
Soluble Carbohydrates ◽  
Soluble Carbohydrate ◽  
Lipid Concentration ◽  
Plasma Lipid Concentration ◽  
Quantitative Studies ◽  
Puparium Formation

Quantitative studies of plasma levels of protein, lipid, and soluble carbohydrate in larvae of O. 8tygia reveal discontinuities at days 6 and 10 of development. From day 3 to 6 plasma levels of protein and lipid increase sharply. After day 6, there is a decline in the concentration of plasma protein which is accelerated. at the onset of pupation. The plasma lipid concentration rises abruptly at day 10, but then declines with the onset of puparium formation. The concentration of soluble carbohydrates in the haemolymph falls slightly between days 6 and 7 of development and commences to rise at about day 10; still higher levels are reached in the quiescent larva and early prepupa.

Apolipoprotein B 3' hypervariable repeat genotype: association with plasma lipid concentration, coronary artery disease, and other restriction fragment polymorphisms

1996 ◽  
Vol 42 (6) ◽  
pp. 927-932 ◽  
Author(s):  
J H Wu ◽  
M S Chern ◽  
S K Lo ◽  
M S Wen ◽  
J T Kao
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Restriction Fragment ◽  
Apolipoprotein B ◽  
Plasma Lipid ◽  
Lipid Concentration ◽  
Stroke Patients ◽  
Plasma Lipid Concentration ◽  
Significant Difference ◽  
Artery Disease

Abstract Apolipoprotein B gene 3' variable number tandem repeat (VNTR) and related regions were amplified by PCR and analyzed by agarose gel electrophoresis. Eighteen VNTR alleles (VNTR25, 26, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 58, 60) and 45 genotypes were observed in 477 Taiwanese subjects. The VNTR35 allele and genotype VNTR35/35 were observed most frequently in this population. The polymorphism information content was 0.62. Some minor alleles, such as VNTR25 and 60, were found only in coronary artery disease (CAD) and stroke patients in our sampling, and no statistically significant difference was observed in VNTR allelic frequency between control and CAD or stroke patients. Significant differences in allelic distribution of some VNTR alleles were observed between our normal Taiwanese population and a Caucasian group studied by others. VNTR43-47 and AluI+ (coding Ala591) restriction fragment length polymorphism (RFLP) as well as VNTR49-60 and EcoRI- (coding Lys4154) RFLP were found to be highly coinherited. No apparent association between the VNTR genotype and plasma lipid concentration was observed; however, for the same genotype, the CAD and stroke patients frequently showed higher lipoprotein(a) and lower HDL cholesterol concentrations than the control group.

Sign in / Sign up

Export Citation Format

Share Document